What is the initial step in a celiac (celiac disease) workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Step in Celiac Disease Workup

The initial step is IgA tissue transglutaminase antibody (tTG-IgA) testing combined with total IgA level measurement, performed while the patient is actively consuming a gluten-containing diet. 1, 2

Primary Serologic Testing

  • tTG-IgA is the preferred screening test with sensitivity of 90-96% and specificity >95%, making it the most reliable initial diagnostic tool 1, 2, 3
  • Total IgA level must be measured simultaneously to identify IgA deficiency, which occurs in 1-3% of celiac patients and causes false-negative tTG-IgA results 2, 4
  • Testing must occur while consuming adequate gluten: at least 10g daily (approximately 3 slices of wheat bread) for 6-8 weeks prior to testing 2, 4

Critical Pitfall to Avoid

  • Never allow patients to start a gluten-free diet before completing diagnostic testing, as this leads to false-negative serologic and histologic results 2, 4
  • If a patient has already eliminated gluten, they must resume a gluten-containing diet for 1-3 months before testing, though some may require several years for histologic relapse 2

When to Measure Total IgA

  • Measure total IgA in all patients being tested for celiac disease, particularly those with first-degree relatives who have the disease 1
  • If IgA deficiency is detected, switch to IgG-based testing: IgG deamidated gliadin peptide (DGP-IgG) or IgG tissue transglutaminase (tTG-IgG) 1, 2
  • Do not use IgG-based tests in patients with normal IgA levels, as they are markedly less accurate in this setting 2

Age-Specific Considerations

  • For children under 2 years: Combine tTG-IgA with IgG and IgA deamidated gliadin peptides to improve sensitivity 1, 2
  • For adults and children over 2 years: tTG-IgA alone is sufficient as the initial test 1

Next Steps After Initial Testing

If tTG-IgA is Elevated

  • When tTG-IgA is >10× upper limit of normal: Perform IgA endomysial antibody (EMA-IgA) as confirmatory testing, which has excellent specificity of 99.6% 1, 2, 4
  • The combination of tTG-IgA >10× upper limit of normal plus positive EMA-IgA approaches 100% positive predictive value for celiac disease 2, 4
  • Proceed to upper endoscopy with multiple duodenal biopsies (at least 6 specimens: 1-2 from duodenal bulb and 4+ from second part of duodenum or beyond) for definitive diagnosis in adults 2, 4

If tTG-IgA is Negative but Clinical Suspicion Remains High

  • Confirm adequate gluten intake and verify total IgA level is normal 2
  • Consider HLA-DQ2 and HLA-DQ8 testing, which has >99% negative predictive value—absence of both alleles essentially rules out celiac disease 1, 2, 4
  • If HLA is positive, proceed to biopsy despite negative serology, as seronegative celiac disease can occur 1, 2

High-Risk Groups Warranting Testing

Even without typical symptoms, test patients with:

  • First-degree relatives of celiac patients (7.5% risk) 1, 2, 3
  • Type 1 diabetes mellitus (5-10% prevalence) 1, 2, 3
  • Autoimmune thyroid disease 2, 3
  • Down syndrome or Turner syndrome 1, 2, 3
  • Unexplained iron deficiency anemia 2, 3
  • Premature osteoporosis 2, 3
  • Unexplained liver transaminase elevations 2, 3

Common Diagnostic Errors

  • Do not rely on symptoms alone to differentiate celiac disease from other gastrointestinal disorders, as clinical presentation is highly variable 1, 5
  • Do not use symptom improvement on gluten-free diet as diagnostic evidence without serologic and histologic confirmation, as this has very low positive predictive value 1
  • Do not combine multiple antibody tests in low-risk populations, as this marginally increases sensitivity but reduces specificity 1
  • Do not use stool studies, small-bowel follow-through, intestinal permeability testing, D-xylose testing, or salivary testing for diagnosis, as these are not validated 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Celiac Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Diagnosis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.